Joy Chaudhari

Joy Chaudhari

Auto-generated profile, based on publicly available information

Joy Chaudhari

Smt. NHL Municipal Medical College, Ahmedabad, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2023 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
ASAbhi Shah
Abhi Shah
VPViraj Panchal
Viraj Panchal
VSVedant Shah
Vedant Shah
BVBhavya Vyas
Bhavya Vyas
HPHarshank Patel
Harshank Patel
JCJoy Chaudhari
Joy Chaudhari

10 November 2023 in The Journal of Liquid Biopsy
Verified
Journal Article
Open access
UZUrvi Zala
Urvi Zala
RPRushi Patel
Rushi Patel
VPViraj Panchal
Viraj Panchal
JCJoy Chaudhari
Joy Chaudhari
VSVedant Shah
Vedant Shah
ASAbhi Shah
Abhi Shah
One of the main techniques for diagnosing lung cancer is still tissue biopsy. The more recent liquid biopsy technique includes the assessment of fragments of cfDNA, ctDNA, and CTCs, which are released by tumour cells and act as biomarkers. After compiling information from the existing literature, we conducted a statistical analysis to evaluate the prognosis and recurrence of NSCLC post-treatment using ctDNA levels. Based on predefined inclusion and exclusion criteria, published studies between 2000 and 2022 from electronic databases with statistical data on ctDNA levels for NSCLC were included. Then, using PRISMA guidelines, we carried out a systematic review of those studies. A total of 7 studies were included in the analysis, and we found a correlation of ctDNA levels for determination of prognosis and recurrence after treatment in NSCLC. Meta-analysis was performed using RevMan version 5.4. A P-value of less than 0.05 was considered significant. Studies were divided into three groups: three months post-surgery. Analysis showed that in <1-week post-surgery group, ctDNA-negative post-treatment detection had an HR of 4.85 (95 % CI: 2.41 to 9.77; p= three months group, with HR of 5.27 (95 % CI: 3.62 to 7.67; p=<0.00001, I2 = 11 %) and HR of 6.62 (95 % CI: 2.85 to 15.35; p=<0.0001, I2 = 64 %) respectively. According to our meta-analysis, patients with NSCLC who were ctDNA negative after surgery had a significantly longer recurrence-free survival than those who were ctDNA positive. As a result, liquid biopsy used to measure ctDNA levels is a useful non-invasive technique to assess the prognosis in such patients. The early detection of recurrence may also allow timely therapeutic intervention, leading to better outcomes.

2 January 2023 in Cureus
Verified
Journal Article
Open access
RPRushi Patel
Rushi Patel
UZUrvi Zala
Urvi Zala
JCJoy Chaudhari
Joy Chaudhari
VPViraj Panchal
Viraj Panchal
ASAbhi Shah
Abhi Shah
Juvenile idiopathic inflammatory myopathies (JIIMs) are a group of diverse, systemic autoimmune diseases that manifest in childhood and are characterized by weakness and chronic inflammation of skeletal muscles. One of the relatively rare variants of JIIMs is juvenile polymyositis (JPM). JPM patients present with proximal and distal muscle weakness, gait instability with falls, muscle pain and tenderness, and high levels of creatine kinase (CK) during adolescence. There are currently few people being diagnosed with JPM, which raises the question of whether or not it is a distinct disease. We discuss the case of a 13-year-old girl who presented to the hospital with generalized body swelling and difficulty swallowing solid food. She also had drooling of saliva during the presentation and a history of difficulty climbing up and down the stairs for three months. Her extensive laboratory workup showed a positive antinuclear antibody (ANA) test and increased muscle enzyme. A muscle biopsy was ordered, and she was diagnosed with JPM. Such a unique presentation has rarely been reported in the pediatric literature. This case report outlines an unusual JPM presentation that could help clinicians identify the condition and start treatment as soon as possible to minimize complications.

12 September 2025 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
PDF file
EGEmmanuel Gbadehan
Emmanuel Gbadehan
MAMohammad Abubaker
Mohammad Abubaker
PAParth Adrejiya
Parth Adrejiya
KHKhwaja Haq
Khwaja Haq
TVTeresa Varghese
Teresa Varghese
AKAshok kumar Kanugula
Ashok kumar Kanugula
Breast cancer typically metastasizes to the lymph nodes, lungs, bones, and liver. However, gastrointestinal (GI) involvement is exceedingly rare, particularly presenting as duodenal ulcers. Such metastases often mimic primary GI malignancies, leading to nonspecific symptoms like abdominal pain, anorexia, bleeding, and vomiting, which can delay accurate diagnosis. Early recognition through appropriate diagnostic evaluations is crucial to prevent disease progression. We report a unique case of an 86-year-old woman with multiple comorbidities who presented with multiple gastrointestinal ulcers. Further investigation revealed these lesions to be manifestations of metastatic breast cancer. This case underscores the importance of considering metastatic breast cancer in the differential diagnosis of atypical gastrointestinal presentations, even in elderly patients without a known history of malignancy.